18F-FDG PET/CT显像评估心脏肿瘤:组织学相关性与临床结局
该研究纳入38例心脏肿瘤患者行18F-FDG PET/CT并随访中位8.5±12.5个月,以组织学为金标准通过ROC曲线确定鉴别良恶性的SUVmax阈值为3.44(灵敏度100%、特异度92.9%)、TBRmax阈值为1.55(灵敏度95.8%、特异度92.9%);恶性者生存率显著低于良性者,SUVmax阈值判定的病变良恶性是死亡的独立预测因子。
要点
- SUVmax=3.44鉴别心脏肿瘤良恶性,灵敏度100%、特异度92.9%。
- TBRmax=1.55鉴别良恶性,灵敏度95.8%、特异度92.9%。
- 恶性心脏肿瘤患者生存率显著低于良性者(P<.05)。
核心结论
- 心脏肿瘤的18F-FDG摄取可鉴别良性与恶性,并可预测生存。
研究设计与样本
- 分析38例接受18F-FDG PET/CT的心脏肿瘤患者,随访中位8.5±12.5个月,以组织学(n=38)为恶性诊断标准。
主要发现
- 原发性良性心脏肿瘤(n=14)SUVmax=2.35±1.31、TBRmax=1.05±0.50,原发性恶性心脏肿瘤(n=11)SUVmax=8.90±4.23、TBRmax=3.82±1.44,心脏转移瘤与淋巴瘤(n=13)SUVmax=14.37±8.05、TBRmax=6.19±3.38,组间18F-FDG摄取差异均有统计学意义(均P<.001)。
- 恶性心脏肿瘤患者生存率显著低于良性心脏肿瘤患者(P<.05)。
- 回归分析显示,以SUVmax阈值判定的病变良恶性是心脏肿瘤患者死亡的独立预测因子(P<.05)。
关键数值与推荐
- SUVmax=3.44为提示恶性的最佳截断值,灵敏度100%、特异度92.9%。
- TBRmax=1.55为提示恶性的最佳截断值,灵敏度95.8%、特异度92.9%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the diagnostic value of 18F-FDG PET/CT in distinguishing benign versus malignant cardiac tumors as well as to assess its prognostic value. METHODS: We analyzed 38 patients with cardiac tumors who underwent 18F-FDG PET/CT and followed for median 8.5 ± 12.5 months. SUVmax and TBRmax (maximum tumor-to-background ratio) by receiver-operating characteristic (ROC) curve analysis were used to obtain threshold for the diagnosis of malignancy as defined by histology (n = 38). Survival was assessed and correlated with the dignity of the lesions and PET parameters. RESULTS: Optimal cut-off values indicating malignancy were as follows: SUVmax = 3.44, with 100% sensitivity and 92.9% specificity, and TBRmax = 1.55, with 95.8% sensitivity and 92.9% specificity. A significant difference of 18F-FDG uptake was observed between primary benign (n = 14, SUVmax = 2.35 ± 1.31, TBRmax = 1.05 ± 0.50) compared to primary malignant cardiac tumors (n = 11, SUVmax = 8.90 ± 4.23, TBRmax = 3.82 ± 1.44) as well as cardiac metastases and lymphoma (n = 13, SUVmax = 14.37 ± 8.05, TBRmax = 6.19 ± 3.38) (all P < .001). Survival rate was significantly lower in patients with malignant as compared to benign cardiac tumors (P < .05). Regression analysis revealed that the lesion dignity determined by the cut-off value of SUVmax was an independent predictor for death in patients with cardiac tumors (P < .05). CONCLUSION: 18F-FDG uptake in cardiac tumors can differentiate between benign and malignant cardiac tumors and predicts survival.
引用
- Meng J, Zhao H, Liu Y, et al. Assessment of cardiac tumors by 18F-FDG PET/CT imaging: Histological correlation and clinical outcomes. J Nucl Cardiol. 2020. PMID: 31933156. doi:10.1007/s12350-019-02022-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。